2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice

IF 8.2 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Cardiac Failure Pub Date : 2025-09-01 DOI:10.1016/j.cardfail.2025.03.005

MASATOSHI MINAMISAWA MD, PhD , TOSHIHISA ANZAI MD, PhD , TAKAYUKI INOMATA MD, PhD , KOICHIRO KINUGAWA MD, PhD , YASUSHI SAKATA MD, PhD , NAOKI SATO MD, PhD , HIROYUKI TSUTSUI MD, PhD , KAZUHIRO YAMAMOTO MD, PhD , MICHIHIRO YOSHIMURA MD, PhD , YOSHIHIKO SAITO MD, PhD , KOICHIRO KUWAHARA MD, PhD

{"title":"2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice","authors":"MASATOSHI MINAMISAWA MD, PhD , TOSHIHISA ANZAI MD, PhD , TAKAYUKI INOMATA MD, PhD , KOICHIRO KINUGAWA MD, PhD , YASUSHI SAKATA MD, PhD , NAOKI SATO MD, PhD , HIROYUKI TSUTSUI MD, PhD , KAZUHIRO YAMAMOTO MD, PhD , MICHIHIRO YOSHIMURA MD, PhD , YOSHIHIKO SAITO MD, PhD , KOICHIRO KUWAHARA MD, PhD","doi":"10.1016/j.cardfail.2025.03.005","DOIUrl":null,"url":null,"abstract":"<div><div>This revised 2023 statement on blood brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of brain (B-type) natriuretic peptide (NT-proBNP) represents an expert consensus that aims to enhance efficient referral from general practitioners or non-cardiovascular specialists, providing a comprehensive, up-to-date perspective on BNP and NT-proBNP in the diagnosis and management of heart failure, with a focus on the following two major modifications: (1) Changes regarding cutoff values for BNP and NT-proBNP (criteria for heart failure diagnosis and referral criteria to cardiovascular specialists); and (2) Content related to heart failure management using BNP and NT-proBNP (BNP-guided therapy).</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 9","pages":"Pages 1453-1459"},"PeriodicalIF":8.2000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiac Failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1071916425001393","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

This revised 2023 statement on blood brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of brain (B-type) natriuretic peptide (NT-proBNP) represents an expert consensus that aims to enhance efficient referral from general practitioners or non-cardiovascular specialists, providing a comprehensive, up-to-date perspective on BNP and NT-proBNP in the diagnosis and management of heart failure, with a focus on the following two major modifications: (1) Changes regarding cutoff values for BNP and NT-proBNP (criteria for heart failure diagnosis and referral criteria to cardiovascular specialists); and (2) Content related to heart failure management using BNP and NT-proBNP (BNP-guided therapy).

查看原文本刊更多论文

2023日本心力衰竭学会关于心力衰竭实践中BNP和NT-proBNP水平的科学声明更新。

修订后的2023年血脑（b型）利钠肽（BNP）和脑（b型）利钠肽n端原激素（NT-proBNP）声明代表了专家共识，旨在提高全科医生或非心血管专科医生的有效转诊，提供BNP和NT-proBNP在心力衰竭诊断和管理中的全面、最新视角，重点关注以下两个主要修改：(1) BNP和NT-proBNP（心衰诊断标准和心血管专家转诊标准）临界值的变化。(2)与BNP和NT-proBNP （BNP引导治疗）心衰管理相关的内容。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cardiac Failure 医学-心血管系统

CiteScore

7.80

自引率

8.30%

发文量

653

审稿时长

21 days

期刊介绍： Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure - pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.